文献速递慢阻肺哮喘

129Xe-MRI通气与腺泡异常凸显肺功能发育不良的意义:NOVELTY ADPro英国亚组研究

129Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudy.
PubMed 文献 · Thorax · 2025-11-14

在NOVELTY ADPro研究中,165名哮喘和/或COPD参与者中43例存在肺功能发育不良(FEV1/FVC<-1.64 z且FEV1>-1.64 z),与43名年龄匹配的正常肺功能者相比,发育不良者129Xe-MRI显示通气缺陷、通气异质性和腺泡尺寸指标显著增加,且1年随访仅发育不良者通气缺陷显著增加。

要点

  • 哮喘和/或COPD伴肺功能发育不良者129Xe-MRI通气缺陷和腺泡异常更显著。
  • 发育不良者1年内通气缺陷显著进展,提示疾病活动性更高。
  • FEV1/FVC与129Xe-MRI通气缺陷和腺泡尺寸相关,尤见于FVC高于正常上限者。

核心结论

  • 哮喘和/或COPD伴肺功能发育不良者较正常肺功能者存在更显著的129Xe-MRI肺部异常,且FEV1/FVC与气道异常程度相关。

研究设计与样本

  • NOVELTY ADPro英国亚组研究,纳入165名医生诊断哮喘和/或COPD参与者,比较43例肺功能发育不良者与43例年龄匹配正常肺功能者。

主要发现

  • 发育不良者通气缺陷中位差4.0%(95%CI 1.42%至5.38%),p<0.001。
  • 发育不良者通气异质性中位差2.56%(95%CI 1.31%至3.56%),p<0.001。
  • 发育不良者腺泡尺寸中位差0.004 cm2.s-1(95%CI 0.0009至0.007),p=0.009。
  • 1年随访仅发育不良者通气缺陷显著增加,中位差0.45%(95%CI 0.09%至2.1%),p=0.016。
  • 发育不良队列中FEV1/FVC与通气缺陷(r=-0.64,R2=0.41,p<0.001)和腺泡尺寸(r=-0.52,R2=0.38,p<0.001)相关。

临床怎么用

  • 对哮喘和/或COPD患者应关注肺功能发育不良(FEV1/FVC<-1.64 z且FEV1>-1.64 z),其提示更重肺部异常。
  • 129Xe-MRI可评估发育不良者的通气缺陷和腺泡异常,辅助识别疾病进展高风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Airways dysanapsis is defined by CT or spirometry as a mismatch between the size of the airways and lung volume and is associated with increased risk of developing chronic obstructive pulmonary disease (COPD). Lung disease in participants with dysanapsis and a label of asthma and/or COPD remains poorly understood. METHODS: In participants with asthma and/or COPD, we used 129Xe-MRI to assess ventilation, acinar dimensions and gas exchange, and pulmonary function tests, and compared people with spirometric dysanapsis (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC)<-1.64 z and FEV1>-1.64 z) to those with normal spirometry (FEV1, FVC and FEV1/FVC>-1.64 z). RESULTS: From 165 participants assessed in the NOVELTY (NOVEL observational longiTudinal studY) ADPro (advanced diagnostic profiling) study with a physician-assigned diagnosis of asthma and/or COPD, 43 had spirometric dysanapsis and were age-matched to 43 participants with normal spirometry. Participants with dysanapsis had significantly increased ventilation defects (median difference (md) (95% CI) = 4.0% (1.42% to 5.38%), p<0.001), ventilation heterogeneity (md (95% CI) = 2.56% (1.31% to 3.56%), p<0.001) and measures of acinar dimensions (md (95% CI) = 0.004 cm2.s-1 (0.0009 to 0.007), p=0.009) from 129Xe-MRI, than those with normal spirometry. At the 1-year follow-up, only participants with dysanapsis had a significant increase in ventilation defects (md (95% CI)=0.45% (0.09% to 2.1%),p=0.016). Lower FEV1/FVC in the dysanapsis cohort was associated with increased ventilation defects (r=-0.64, R2=0.41, p<0.001) and increased acinar dimensions (r=-0.52, R2=0.38, p<0.001), with the highest values seen in those with an FVC above the upper limit of normal. CONCLUSIONS: Participants with asthma and/or COPD, presenting to primary care with spirometric dysanapsis, exhibited increased lung abnormalities on 129Xe-MRI, when compared with those with normal spirometry. Spirometric dysanapsis in asthma and/or COPD is therefore associated with significant lung disease, and the FEV1/FVC is related to the degree of airways abnormality on 129Xe-MRI.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Smith LJ, Marshall H, Jakymelen D, et al. 129Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudy. Thorax. 2025. PMID: 40425296. doi:10.1136/thorax-2024-222347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。